Filing Details
- Accession Number:
- 0001209191-22-048607
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-02 20:00:21
- Reporting Period:
- 2022-09-01
- Accepted Time:
- 2022-09-02 20:00:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1630627 | Treace Medical Concepts Inc. | TMCI | Surgical & Medical Instruments & Apparatus (3841) | 471052611 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1858105 | E. Daniel Owens | 203 Ft Wade Road Suite 150 Ponte Vedra FL 32081 | Chief Human Resources Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-01 | 1,000 | $7.03 | 11,700 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-01 | 1,000 | $19.50 | 10,700 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-09-02 | 1,500 | $7.02 | 12,200 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-02 | 1,500 | $20.04 | 10,700 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option Right to Buy | Disposition | 2022-09-01 | 1,000 | $0.00 | 1,000 | $7.03 |
| Common Stock | Stock Option Right to Buy | Disposition | 2022-09-02 | 1,500 | $0.00 | 1,500 | $7.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 194,125 | 2031-02-02 | No | 4 | M | Direct | |
| 192,625 | 2031-02-02 | No | 4 | M | Direct |
Footnotes
- Includes 6,700 RSUs.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.1600 to $19.8000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025.
Billionaire Hedge Funds
